
    
      The study will be performed in adult patients with autoantibody (ANA) positive SLE, as
      defined by the American College of Rheumatology (ACR) 1997 criteria or System Lupus
      International Collaborating Clinic (SLICC) 2009 criteria who are receiving standard of care
      therapy for SLE.
    
  